You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ose2101

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])

Recruiting
  • Platinum-sensitive Ovarian Cancer
  • Relapsed Ovarian Cancer
  • OSE2101
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Angers, France
  • +27 more
Jul 25, 2022

Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer Trial in France (FOLFIRI, OSE2101)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Amiens, France
  • +27 more
Oct 19, 2021

Non Small Cell Lung Cancer Trial in Worldwide (OSE2101, Docetaxel, Pemetrexed)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • OSE2101
  • +2 more
  • Burbank, California
  • +76 more
Mar 5, 2021